Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Aβ42/40 ratio to identify presence of brain amyloid.

Autor: Meyer MR; C2N Diagnostics, St. Louis, Missouri, USA., Kirmess KM; C2N Diagnostics, St. Louis, Missouri, USA., Eastwood S; C2N Diagnostics, St. Louis, Missouri, USA., Wente-Roth TL; C2N Diagnostics, St. Louis, Missouri, USA., Irvin F; C2N Diagnostics, St. Louis, Missouri, USA., Holubasch MS; C2N Diagnostics, St. Louis, Missouri, USA., Venkatesh V; C2N Diagnostics, St. Louis, Missouri, USA., Fogelman I; C2N Diagnostics, St. Louis, Missouri, USA., Monane M; C2N Diagnostics, St. Louis, Missouri, USA., Hanna L; Center for Statistical Sciences, Brown University School of Public Health, Providence, Rhode Island, USA., Rabinovici GD; UCSF, San Francisco, California, USA., Siegel BA; School of Medicine, Washington University, St. Louis, Missouri, USA., Whitmer RA; UC Davis, Sacramento, California, USA., Apgar C; American College of Radiology, Philadelphia, Pennsylvania, USA., Bateman RJ; School of Medicine, Washington University, St. Louis, Missouri, USA., Holtzman DM; School of Medicine, Washington University, St. Louis, Missouri, USA., Irizarry M; Eisai Inc., Nutley, New Jersey, USA., Verbel D; Eisai Inc., Nutley, New Jersey, USA., Sachdev P; Eisai Inc., Nutley, New Jersey, USA., Ito S; Eisai Co., Ltd., Tokyo, Japan., Contois J; C2N Diagnostics, St. Louis, Missouri, USA., Yarasheski KE; C2N Diagnostics, St. Louis, Missouri, USA., Braunstein JB; C2N Diagnostics, St. Louis, Missouri, USA., Verghese PB; C2N Diagnostics, St. Louis, Missouri, USA., West T; C2N Diagnostics, St. Louis, Missouri, USA.

Publikováno v: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2024 May; Vol. 20 (5), pp. 3179-3192. Date of Electronic Publication: 2024 Mar 16.

The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells

Autor: Ishtiaq, S., Edwards, S., Sankaralingam, A., Evans, B.A.J., Elford, C., Frost, M.L., Fogelman, I., Hampson, G.

Publikováno v: In Cytokine February 2015 71(2):154-160

Clinical role of bisphosphonate therapy

Autor: Hampson G, Fogelman I

Publikováno v: International Journal of Women's Health, Vol 2012, Iss default, Pp 455-469 (2012)

Geeta Hampson,1,2 Ignac Fogelman1,31Osteoporosis Screening Unit, Guy’s Hospital, 2Department of Chemical Pathology, St Thomas’ Hospital, 3Department of Nuclear Medicine, Guy’s Hospital, London, UKAbstract: Bisphosphonates (BPs) are synthetic an

Externí odkaz: https://doaj.org/article/d9e84c858eda44c48a3ae0c3023ba28a

Effect of increasing vertebral marrow fat content on BMD measurement, T-Score status and fracture risk prediction by DXA

Autor: Blake, G.M. ^⁎, Griffith, J.F., Yeung, D.K.W., Leung, P.C., Fogelman, I.

Publikováno v: In Bone 2009 44(3):495-501

Comparison of ordered-subset expectation maximization and filtered back projection reconstruction based on quantitative outcome from dynamic [18F]NaF PET images.

Autor: Wong JM; Department of Anaesthesia, Royal Berkshire Hospitals NHS Foundation Trust, Reading., Puri T; Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, Kings College London, St Thomas' Hospital, London., Siddique MM; Radcliffe Department of Medicine, John Radcliffe Hospital, Headley Way, Headington, Oxford., Frost ML; Clinical Trials & Statistics Unit (ICR-CTSU), Institute of Cancer Research, Sutton., Moore AEB; Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, Kings College London, St Thomas' Hospital, London., Blake GM; Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, Kings College London, St Thomas' Hospital, London., Fogelman I; Osteoporosis Research Unit, Guy's & St Thomas' Hospital, King's College London, London, UK.

Publikováno v: Nuclear medicine communications [Nucl Med Commun] 2021 Jun 01; Vol. 42 (6), pp. 699-706.